Skye Bioscience

(NASDAQ) SKYE

Current Price$0.93

Market Cap$37.23M

Since IPO (2014)-100%

5 Year-97%

1 Year-51%

1 Month+61%

Skye Bioscience Financials at a Glance

Market Cap

$37.23M

Revenue (TTM)

$0.00

Net Income (TTM)

$55.92M

EPS (TTM)

$-1.41

P/E Ratio

-0.75

Dividend

$0.00

Beta (Volatility)

0.65 (Low)

Dividend

$0.00

Beta (Volatility)

0.65 (Low)

Price

$0.93

Volume

363,235

Open

$1.06

Price

$0.93

Volume

363,235

Open

$1.06

Previous Close

$0.93

Daily Range

$0.92 - $1.07

52-Week Range

$0.57 - $5.75

Dividend

$0.00

Beta (Volatility)

0.65 (Low)

Price

$0.93

Volume

363,235

Open

$1.06

Previous Close

$0.93

Daily Range

$0.92 - $1.07

52-Week Range

$0.57 - $5.75

SKYE News

Skye (SKYE) Q2 R&D Soars 249% No Revenue

Motley Fool Markets TeamAug 7, 2025

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Skye Bioscience

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Punit S. Dhillon

Website

skyebioscience.com

Headquarters

San Diego, CA 92130, US

SKYE Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-127%

Return on Capital

-3%

Return on Assets

-2%

Earnings Yield

-1.33%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$37.23M

Shares Outstanding

35.13M

Volume

363.24K

Avg. Volume

554.76K

Financials (TTM)

Gross Profit

$723.35K

Operating Income

$58.16M

EBITDA

$57.44M

Operating Cash Flow

$43.06M

Capital Expenditure

$6.31K

Free Cash Flow

$43.07M

Cash & ST Invst.

$25.74M

Total Debt

$273.65K

Skye Bioscience Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$180.01K

N/A

Gross Margin

0.00%

N/A

Market Cap

$37.23M

N/A

Market Cap/Employee

$2.33M

N/A

Employees

N/A

Net Income

$14.44M

-48.2%

EBITDA

$40.93M

+525.6%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$25.46M

-62.5%

Accounts Receivable

$10.47K

+106.8%

Inventory

$0.00

N/A

Long Term Debt

$84.00K

-69.2%

Short Term Debt

$189.65K

+4.0%

Return on Assets

-1.98%

N/A

Return on Invested Capital

-2.89%

N/A

Free Cash Flow

$9.77M

-18.8%

Operating Cash Flow

$9.77M

-19.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

INMBINmune Bio, Inc.

INMBINmune Bio, Inc.$1.40-4.76%

ALGSAligos Therapeutics, Inc.

ALGSAligos Therapeutics, Inc.$6.29-2.18%

LVTXLAVA Therapeutics N.V.

LVTXLAVA Therapeutics N.V.$1.74-3.87%

XLOXilio Therapeutics, Inc.

XLOXilio Therapeutics, Inc.$7.92-3.18%

XFORX4 Pharmaceuticals, Inc.

XFORX4 Pharmaceuticals, Inc.$4.12-2.14%

BRNSBarinthus Biotherapeutics plc

BRNSBarinthus Biotherapeutics plc$0.61-3.17%

CVMCEL-SCI Corporation

CVMCEL-SCI Corporation$3.04-6.75%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$11.30+0.05%

POETPoet Technologies

POETPoet Technologies$8.03+0.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$60.74-0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.14-0.01%

SOFISoFi Technologies

SOFISoFi Technologies$18.36-0.02%

RIGTransocean

RIGTransocean$6.79+0.04%

JOBYJoby Aviation

JOBYJoby Aviation$8.93-0.01%

Questions About SKYE

What is the current price of Skye Bioscience?

Skye Bioscience is trading at $0.93 per share.

What is the 52-week range for Skye Bioscience?

Over the past 52 weeks, Skye Bioscience has traded between $0.57 and $5.75.

How much debt does Skye Bioscience have?

As of the most recent reporting period, Skye Bioscience reported total debt of $273,646.

How much cash does Skye Bioscience have on hand?

Skye Bioscience reported $5.88M in cash and cash equivalents in its most recent financial results.

What is Skye Bioscience’s dividend yield?

Skye Bioscience does not currently have a dividend yield.

Skye Bioscience

Skye Bioscience Financials at a Glance

SKYE News

Skye (SKYE) Q2 R&D Soars 249% No Revenue

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Skye Bioscience

SKYE Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Skye Bioscience Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About SKYE

What is the current price of Skye Bioscience?

What is the 52-week range for Skye Bioscience?

How much debt does Skye Bioscience have?

How much cash does Skye Bioscience have on hand?

What is Skye Bioscience’s dividend yield?

Premium Investing Services